Important Litigation Notice for Aardvark Therapeutics Investors: Act Before Deadline

Aardvark Therapeutics Investors Need to Act by Deadline

In recent news, Aardvark Therapeutics, Inc. (NASDAQ: AARD) investors are being urged to take action due to a looming deadline tied to a lawsuit. If you invested over $100,000 in Aardvark Therapeutics between February 13, 2025 and May 14, 2026, it is crucial that you pay attention. The Shareholders Foundation, a renowned entity in shareholder advocacy, has announced October 31, 2026 as the final day for claims to be filed. The firm encourages affected investors to reach out and understand their legal options and possible compensations.

On August 14, 2024, a lawsuit was initiated against Aardvark Therapeutics, citing serious allegations regarding the conduct surrounding their recent initial public offering (IPO). According to the plaintiff, the offering documents provided during the February 13, 2025 IPO were carelessly prepared. This negligence resulted in material misstatements and omissions that misled potential investors. The lawsuit claims these documents did not adhere to proper rules and regulations, thereby violating investor trust. Furthermore, between the outlined dates, the company's public statements were reportedly misleading regarding its operational metrics.

The crux of the allegations revolves around ARD-101, a product that the defendants purported to be safe. The lawsuit contends that the perceived safety of ARD-101 was overstated, affecting both clinical and regulatory projections. As a direct result, investors were led to believe in the product's promising future, which was ultimately based on deceptive information. Those who purchased shares are encouraged to contact the Shareholders Foundation, as they stand to gain valuable insights into the ongoing proceedings and understand how these developments may affect their investments.

For those ready to act, they can reach the Shareholders Foundation by calling +1 (858) 779 - 1554 or emailing them at [email protected]. The foundation is located in San Diego, CA and specializes in monitoring shareholder issues while guiding investors through securities-related legal matters.

If you're an investor in Aardvark Therapeutics, the timeframe to seek justice could be closing soon. Stay informed about your rights and options. The path may require legal action, and knowledgeable assistance is available to help you navigate this challenging landscape. Remember, October 31, 2026, is the day to circle on your calendar for this matter.

A Call to Action

This news serves as a crucial reminder for investors to stay vigilant and proactive. Mistakes in the corporate arena can lead to significant losses, and investors deserve transparency and accountability from the companies they trust with their investments.

Contact Information:
Michael Daniels,
Shareholders Foundation, Inc.,
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North, Suite 423
San Diego, CA 92108